Our results demonstrate that Analog-1 specifically inhibited the viability of NB and melanoma cell lines without any cytotoxic effect on fibroblasts, suggesting that activation of RNF5 represents a potential anti-tumor treatment strategy. This evidence concerns the gene RNF5 and melanoma.